Abstract:Treatment options for myocarditis are currently limited. Inhibition of calpains has been shown to prevent Coxsackievirus B3 (CVB3)-induced cardiac injuries, but the underlying mechanism of action of calpains has not been elucidated. We investigated whether NOD-, LRR-, and pyrin domain-containing 3 (NLRP3) inflammasome participated in CVB3-induced myocarditis, and investigated the effects of calpain-1 on CVB3-induced cardiac injury. NLRP3 inflammasome was activated in CVB3-infected hearts, evidenced by elevated protein levels of NLRP3, N-terminal domain of Gasdermin D, and cleaved caspase-1, and the increased co-localization of NLRP3 and apoptosis-associated speck-like protein. The intraperitoneal administration of MCC950, a selective inhibitor of the NLRP3 inflammasome, led to decreased levels of serum creatine kinase-MB, cardiac troponin I, lactate dehydrogenase, interleukin-18, interleukin-1β, prevention of the infiltration of inflammatory cells, and improvement of cardiac function under CVB3 infection. Transgenic mice overexpressing the endogenous calpain inhibitor calpastatin (Tg-CAST mice) exhibited not only decreased apoptosis, inflammation, fibrosis, and enhanced cardiac function but also inhibition of NLRP3 inflammasome and pyroptosis. The selective inhibition of calpain-1 using PD151746 protected cardiomyocytes in vitro from CVB3 infection by downregulating NLRP3 inflammasome and, thus, preserved cell viability. Mechanistically, we showed that mitochondrial dysfunction preceded inflammatory response after CVB3 treatment and elimination of mitochondrial reactive oxygen species (ROS) using mitochondria-targeted antioxidants (mito-TEMPO) recapitalized the phenotype observed in Tg-CAST mice. Furthermore, the promotion or inhibition of calpain-1 activation in vitro regulated the mitochondrial respiration chain. Mito-TEMPO reversed calpain-1-mediated NLRP3 inflammation activation and cell death. We also found that mitochondrial calpain-1, which was increased after CVB3 stimulation, activated the NLRP3 inflammasome and resulted in cell death. Furthermore, ATP synthase-α (ATP5A1) was revealed to be the cleaving target of calpain-1 after CVB3 treatment. Downregulating ATP5A1 using ATP5A1-small interfering RNA impaired mitochondrial function, decreased cell viability, and induced NLRP3 inflammasome activation. In conclusion, CVB3 infection induced calpain-1 accumulation in mitochondria, and led to subsequent ATP5A1 cleavage, mitochondrial ROS overproduction, and impaired mitochondrial function, eventually causing NLRP3 inflammasome activation and inducing pyroptosis. Therefore, our findings established the role of calpain in viral myocarditis and unveiled its underlying mechanism of its action. Calpain appears as a promising target for the treatment of viral myocarditis.

Inhibition of Calpain Alleviates Coxsackievirus B3-induced Myocarditis Through Suppressing the Canonical NLRP3 Inflammasome/caspase-1-mediated and Noncanonical Caspase-11-mediated Pyroptosis Pathways

Inhibition of Calpain Alleviates Apoptosis in Coxsackievirus B3-induced Acute Virus Myocarditis Through Suppressing Endoplasmic Reticulum Stress.

Mitochondrial calpain-1 activates NLRP3 inflammasome by cleaving ATP5A1 and inducing mitochondrial ROS in CVB3-induced myocarditis

PS-B06-5: MITOCHONDRIAL CALPAIN-1 ACTIVATES NLRP3 INFLAMMASOME VIA CLEAVING ATP5A1 AND INDUCING MITOCHONDRIAL ROS IN CVB3-INDUCED MYOCARDITIS

Dual Roles of Calpain in Facilitating Coxsackievirus B3 Replication and Prompting Inflammation in Acute Myocarditis.

Inhibition of calpain reduces cell apoptosis by suppressing mitochondrial fission in acute viral myocarditis

Calpain Regulates CVB3 Induced Viral Myocarditis by Promoting Autophagic Flux Upon Infection.

A Study On The Correlation Between Calpain Mrna Expression And Cardiocyte Apoptosis In Acute Murine Coxsackievirus B3 Myocarditis

Coxsackievirus B3-induced Calpain Activation Facilitates the Progeny Virus Replication Via a Likely Mechanism Related with Both Autophagy Enhancement and Apoptosis Inhibition in the Early Phase of Infection: an in Vitro Study in H9c2 Cells.

Cathepsin B aggravates coxsackievirus B3-induced myocarditis through activating the inflammasome and promoting pyroptosis

Involvement of NLRP3 Inflammasome in CVB3-induced Viral Myocarditis.

miR-19b-3p/PKNOX1 Regulates Viral Myocarditis by Regulating Macrophage Polarization

[Effect and mechanism of 1, 25(OH)2D3 on myocardial inflammation induced by Coxsackie virus B3 in mice]

The Severity of CVB3-Induced Myocarditis Can Be Improved by Blocking the Orchestration of NLRP3 and Th17 in Balb/c Mice

Mesenchymal stromal cells inhibit NLRP3 inflammasome activation in a model of Coxsackievirus B3-induced inflammatory cardiomyopathy

Macrophage CAPN4 regulates CVB3-induced cardiac inflammation and injury by promoting NLRP3 inflammasome activation and phenotypic transformation to the inflammatory subtype

Inhibition of Inos Protects Cardiomyocytes Against Coxsackievirus B3-induced Cell Injury by Suppressing Autophagy.

Activation of CaMKII Via ER-stress Mediates Coxsackievirus B3-induced Cardiomyocyte Apoptosis.

Involvement of Endoplasmic Reticulum Stress-Mediated C/EBP Homologous Protein Activation in Coxsackievirus B3-Induced Acute Viral Myocarditis

CTLA4-Ig Relieves Inflammation in Murine Models of Coxsackievirus B3-induced Myocarditis.

MG-132 Attenuates Cardiac Deterioration of Viral Myocarditis Via AMPK Pathway